Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the...
Source: prnewswire.com
Page 3 - Tim Clackson News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tim Clackson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tim Clackson Today - Breaking & Trending Today
Theseus Pharmaceuticals Addressing KIT, EGFR Resistance With Pan-Variant Inhibitors
The company is conducting a clinical trial of a pan-variant inhibitor for KIT-mutant GIST and hopes to advance an EGFR pan-variant inhibitor to the clinic soon.
Source: precisiononcologynews.com
Theseus Pharmaceuticals Announces Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the...
Source: prnewswire.com
Theseus Pharmaceuticals to Participate Virtually in SVB Leerink Global Healthcare Conference
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer...
Source: prnewswire.com
Theseus Pharmaceuticals to Participate Virtually in SVB Leerink Global Healthcare Conference
/PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer...
Source: prnewswire.com